DonorPlex™ Pooled Donor Human Hepatocytes Enable the Next Level of Reliability | Lonza

Watch our expert, Maureen Bunger, PhD, explain how our patented manufacturing process ensures that the DonorPlex™ Hepatocytes exhibit improved phenotype reproducibility. Additionally, we have a proprietary algorithm that predicts yield, viability and functional phenotype prior to manufacture which ensures individual customer specifications are met.
Learn more about DonorPlex™ Pooled Donor Human Hepatocytes:
bioscience.lon...
Learn how Lonza can support your liver research applications:
bioscience.lon...
DonorPlex™ Pooled Donor Human Hepatocytes products from Lonza:
bioscience.lon...
Start your custom pool of primary hepatocytes:
bioscience.lon...
#ADME #Toxicology #Drugmetabolism #pharmacokinetic #DrugDiscovery #hepatocytes #primarycells #FDA #Lonza #DrugDrugInteraction #DDI